You can buy or sell AKCA and other stocks, options, ETFs, and crypto commission-free!
Akcea Therapeutics, Inc. Common Stock, also called Akcea Therapeutics, is a biopharmaceutical company. Read More It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. The listed name for AKCA is Akcea Therapeutics, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 3, After Hours